Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-09-003984
Filing Date
2009-03-18
Accepted
2009-03-17 19:49:14
Documents
4
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c82249e10vk.htm 10-K 1150339
2 EXHIBIT 31.1 c82249exv31w1.htm EX-31.1 6743
3 EXHIBIT 32.1 c82249exv32w1.htm EX-32.1 3757
4 GRAPHIC c82249c8224901.gif GRAPHIC 17783
  Complete submission text file 0001362310-09-003984.txt   1186925
Mailing Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080
Business Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080 (650) 624-1000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26483 | Film No.: 09689510
SIC: 2834 Pharmaceutical Preparations